Softbank leads $127 million funding round for Brazilian healthcare startup Alice
Reuters
Published Dec 21, 2021 03:14PM ET
SAO PAULO (Reuters) - Brazilian healthcare startup Alice has raised $127 million in its series C funding round led by Softbank (OTC:SFTBY) Latin America Fund, the company said on Tuesday.
Other investors include shareholders Kaszek Ventures and ThornTree Capital Partners and new investors such as Allen & Company LLC, G Squared, Globo Ventures and StepStone.
Other shareholders in Alice include Canary, Endeavor Catalyst e Maya Capital.
Alice did not disclose its valuation in the round. CEO and co-founder André Florence said the funds will be used to invest in technology and services to companies interested in providing healthcare to employees.
Paolo Passoni, director at Softbank Latin America Fund, said less than 25% of Brazilians have access to private healthcare and Alice is one of the companies trying to tackle the healthcare problems.
The startup, focused in the Sao Paulo metropolitan area, provides healthcare to around 6,000 people and has 10 hospitals and 200 medical labs as partners. Alice recently acquired startup Cuidas, focused in providing healthcare products to companies.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.